Givaudan | GIVN - Equity Capital And Reserves


Givaudan reported CHF4.54B in Equity Capital and Reserves for its fiscal semester ending in December of 2025.





Equity Capital And Reserves Change Date
Air Liquide EUR 26.52B 303.1M Jun/2026
Akzo Nobel EUR 4.85B 28M Jun/2026
Anheuser-Busch USD 93.5B 4.24B Jun/2026
Arkema EUR 6.78B 176.8M Jun/2026
Associated British Foods GBP 11.06B 64M Dec/2025
BASF EUR 36.32B 846M Jun/2026
Bayer EUR 28.85B 2.9B Mar/2026
Beiersdorf EUR 8.6B 133M Dec/2025
British American Tobacco GBP 46.49B 453M Jun/2026
Covestro EUR 7B 908M Dec/2025
Croda International GBP 2.28B 53.3M Dec/2024
Danone EUR 16.61B 308M Jun/2026
Diageo GBP 10.87B 730M Jun/2026
Fresenius EUR 19.7B 766M Jun/2026
Fresenius Medical Care EUR 14.2B 13.95B Mar/2026
Givaudan CHF 4.54B 430M Dec/2025
Heineken EUR 20.61B 2.9B Dec/2025
Henkel EUR 20.97B 479M Jun/2026
International Flavors Fragrances USD 13.98B 144M Jun/2026
Johnson Matthey GBP 2.02B 85M Jun/2026
Kerry EUR 6.11B 158.2M Jun/2026
Lonza CHF 9.13B 513M Dec/2025
L'Oréal EUR 33.84B 1.11B Jun/2026
Merck EUR 29.74B 1.15B Mar/2026
Nestle CHF 29.23B 3.58B Jun/2026
Pernod Ricard EUR 3.44B 12.78B Dec/2025
Reckitt Benckiser GBP 6.7B 1.39B Dec/2024
SGS CHF 877M 188M Dec/2024
Sika AG CHF 6.66B 481.4M Dec/2025
Solvay EUR 1.11B 70M Jun/2026
Tate & Lyle GBP 1.6B 52M Jun/2026
Umicore EUR 2.66B 424.8M Jun/2026
Victrex GBP 361.9M 71.6M Jun/2026